Skip to main content
Livermore
Livermore
ZHEN

Morgan Stanley

SEC CIK
0000895421
Latest filing
Aug 13, 2026

SCPH holding history

scPharmaceuticals Inc. in every 13F filed by Morgan Stanley, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

SCPH overviewAll 13F holders of SCPHFull Q2 2026 holdings

Shares (Q4 2025)
0
Sold out in Q4 2025
Value
$0
% of portfolio
0.0%
Quarters held
19
Since Q1 2021
Holdings of SCPH by Morgan Stanley, by quarter
QuarterSharesValue% of portfolioShare changeActionAll holders
Q4 20250$00.0%−1,672,825−100.0%Sold outHolders
Q3 20251,672,825$9.48M<0.1%−475,061−22.1%ReducedHolders
Q2 20252,147,886$8.18M<0.1%+261,745+13.9%AddedHolders
Q1 20251,886,141$4.96M<0.1%−23,947−1.3%ReducedHolders
Q4 20241,910,088$6.76M<0.1%+1,577,434+474.2%AddedHolders
Q3 2024332,654$1.52M<0.1%+111,363+50.3%AddedHolders
Q2 2024221,291$962.6K<0.1%+40,571+22.4%AddedHolders
Q1 2024180,720$907.2K<0.1%−17,866−9.0%ReducedHolders
Q4 2023198,586$1.25M<0.1%−936,993−82.5%ReducedHolders
Q3 20231,135,579$8.09M<0.1%−25,786−2.2%ReducedHolders
Q2 20231,161,365$11.8M<0.1%−6,196−0.5%ReducedHolders
Q1 20231,167,561$10.6M<0.1%+1,018,583+683.7%AddedHolders
Q4 2022148,978$1.07M<0.1%+55,689+59.7%AddedHolders
Q3 202293,289$608.0K<0.1%−2,414−2.5%ReducedHolders
Q2 202295,703$461.0K<0.1%+9,118+10.5%AddedHolders
Q1 202286,585$492.0K<0.1%+11,750+15.7%AddedHolders
Q4 202174,835$375.0K<0.1%+4,742+6.8%AddedHolders
Q3 202170,093$465.0K<0.1%+8,929+14.6%AddedHolders
Q2 202161,164$374.0K<0.1%+6,875+12.7%AddedHolders
Q1 202154,289$361.0K<0.1%––Holders

Livermore's 13F data starts with Q1 2021, so Q1 2021 has no change from the previous quarter.